Oncologix Tech Inc (OCLG) 0.0055 $OCLG
Oncologix Signs Letter of Intent with Second Medical Products Company; Secures $1,200,000 from Senior Revolving Credit Facility
ACCESSWIRE - Thu Aug 28, 9:45AM CDT
ALEXANDRIA, LA / ACCESSWIRE / August 28, 2014 / Oncologix Tech Inc. (OTC Pink:OCLG) (PINKSHEETS: OCLG), a fully reporting medical holding company, announced today that it has negotiated final terms on a second tranche of funding in the amount of $1,200,000 from its $4,000,000 revolving line of credit from its Senior Lender. This comes on the heels of the signing of a Letter of Intent (LOI) with another Medical Products Company. The Company must continue to meet specific monthly reporting and collateral requirements to further draw upon the revolving credit facility.
Oncologix (OCLG) Plans Expansion; Letter of Intent (LOI) Executed with Medical Product Company
ACCESSWIRE - Thu Jul 24, 8:16AM CDT
ALEXANDRIA, LA / ACCESSWIRE / July 24, 2014 / Oncologix Tech Inc. (OTCPINK: OCLG), a fully reporting, diversified medical holding company with operating businesses units in medical device, healthcare services and medical products and technologies, has executed a Letter of Intent (LOI) to acquire a speciality medical products company.
Oncologix (OCLG) Hires Industry Executive for Company Medical Products & Technology Division
ACCESSWIRE - Tue Jul 22, 8:19AM CDT
ALEXANDRIA, LA / ACCESSWIRE / July 22, 2014 / Oncologix Tech Inc. (OTC PINK: OCLG) (PINKSHEETS: OCLG), a fully reporting, diversified medical holding company with operating business units in medical device, healthcare services and medical products and technologies, has agreed to terms with Mr. Harold Halman, to serve as the President/COO of the newly formed Medical Products and Technology Division.
Oncologix Enters Medical Product & Technology Markets
ACCESSWIRE - Thu Jul 17, 8:15AM CDT
ALEXANDRIA, LA / ACCESSWIRE / July 17, 2014 / Oncologix Tech Inc. (OTCPINK: OCLG), A diversified medical holding company with divisions in medical devices and healthcare services announces its expansion into the Medical Products and Technology markets.
Oncologix Post Solid Revenue Growth and Continued Financial Improvements
ACCESSWIRE - Wed Jul 16, 8:17AM CDT
ALEXANDRIA, LA / ACCESSWIRE / July 15, 2014 / Oncologix Tech Inc. (OTC Pink: OCLG), a diversified medical holding company with division in medical devices and healthcare services released its Third Quarter and YTD Fiscal 2014 results.
10-K/A: ONCOLOGIX TECH INC.
Edgar Online - Thu Dec 19, 1:41PM CST
Item 7. Management's discussion and Analysis of Financial Condition and Results of Operations
Oncologix Tech Acquires Angels of Mercy; Gains Leading Healthcare Service Company
Marketwire - Mon Aug 05, 11:02AM CDT
Oncologix Tech Inc. (OTCQB: OCLG), announced today the Company has purchased 100% of the common stock of Angels of Mercy, Inc., a leader in the Personal Care Attendant (PCA) healthcare services industry.
Oncologix (OCLG) Plans Expansion; Talks Underway with Two Healthcare Service Providers
PR Newswire - Thu May 30, 1:55PM CDT
Oncologix Tech Inc. (OTCBB: OCLG), a diversified medical device and healthcare services company operating businesses in medical device cancer detection, prevention and healthcare services, has opened negotiations to acquire two healthcare service providers. "We have signed non-binding letters of intent with two leading providers of healthcare services to the elderly and expect to announce the details of that transaction, as well as one other, in the next 45 days," said CEO Wayne Erwin today.
Oncologix Tech Inc. (OCLG) Acquires Dotolo; Gains Ongoing Sales, Patents, and New CEO
PR Newswire - Tue Apr 02, 8:28AM CDT
Oncologix Tech Inc. (OTCBB: OCLG), a diversified medical device and healthcare company acquiring businesses in medical device cancer detection and prevention and healthcare services, has purchased all of the outstanding common stock of Dotolo Research Corporation. Dotolo is the leading global colon cleansing and bowel preparation medical device manufacturer, with more than two decades of product research, development and sales. Additional information can be found in the Company's Form 8-K as filed with the SEC.
Oncologix Signs Letter of Intent with Second Medical Products Company; Secures $1,200,000 from Senior Revolving Credit Facility
ACCESSWIRE - Thu Aug 28, 9:45AM CDT
ALEXANDRIA, LA / ACCESSWIRE / August 28, 2014 / Oncologix Tech Inc. (OTC Pink:OCLG) (PINKSHEETS: OCLG), a fully reporting medical holding company, announced today that it has negotiated final terms on a second tranche of funding in the amount of $1,200,000 from its $4,000,000 revolving line of credit from its Senior Lender. This comes on the heels of the signing of a Letter of Intent (LOI) with another Medical Products Company. The Company must continue to meet specific monthly reporting and collateral requirements to further draw upon the revolving credit facility.
Oncologix (OCLG) Plans Expansion; Letter of Intent (LOI) Executed with Medical Product Company
ACCESSWIRE - Thu Jul 24, 8:16AM CDT
ALEXANDRIA, LA / ACCESSWIRE / July 24, 2014 / Oncologix Tech Inc. (OTCPINK: OCLG), a fully reporting, diversified medical holding company with operating businesses units in medical device, healthcare services and medical products and technologies, has executed a Letter of Intent (LOI) to acquire a speciality medical products company.
Oncologix (OCLG) Hires Industry Executive for Company Medical Products & Technology Division
ACCESSWIRE - Tue Jul 22, 8:19AM CDT
ALEXANDRIA, LA / ACCESSWIRE / July 22, 2014 / Oncologix Tech Inc. (OTC PINK: OCLG) (PINKSHEETS: OCLG), a fully reporting, diversified medical holding company with operating business units in medical device, healthcare services and medical products and technologies, has agreed to terms with Mr. Harold Halman, to serve as the President/COO of the newly formed Medical Products and Technology Division.
Oncologix Enters Medical Product & Technology Markets
ACCESSWIRE - Thu Jul 17, 8:15AM CDT
ALEXANDRIA, LA / ACCESSWIRE / July 17, 2014 / Oncologix Tech Inc. (OTCPINK: OCLG), A diversified medical holding company with divisions in medical devices and healthcare services announces its expansion into the Medical Products and Technology markets.
Oncologix Post Solid Revenue Growth and Continued Financial Improvements
ACCESSWIRE - Wed Jul 16, 8:17AM CDT
ALEXANDRIA, LA / ACCESSWIRE / July 15, 2014 / Oncologix Tech Inc. (OTC Pink: OCLG), a diversified medical holding company with division in medical devices and healthcare services released its Third Quarter and YTD Fiscal 2014 results.
10-K/A: ONCOLOGIX TECH INC.
Edgar Online - Thu Dec 19, 1:41PM CST
Item 7. Management's discussion and Analysis of Financial Condition and Results of Operations
Oncologix Tech Acquires Angels of Mercy; Gains Leading Healthcare Service Company
Marketwire - Mon Aug 05, 11:02AM CDT
Oncologix Tech Inc. (OTCQB: OCLG), announced today the Company has purchased 100% of the common stock of Angels of Mercy, Inc., a leader in the Personal Care Attendant (PCA) healthcare services industry.
Oncologix (OCLG) Plans Expansion; Talks Underway with Two Healthcare Service Providers
PR Newswire - Thu May 30, 1:55PM CDT
Oncologix Tech Inc. (OTCBB: OCLG), a diversified medical device and healthcare services company operating businesses in medical device cancer detection, prevention and healthcare services, has opened negotiations to acquire two healthcare service providers. "We have signed non-binding letters of intent with two leading providers of healthcare services to the elderly and expect to announce the details of that transaction, as well as one other, in the next 45 days," said CEO Wayne Erwin today.
Oncologix Tech Inc. (OCLG) Acquires Dotolo; Gains Ongoing Sales, Patents, and New CEO
PR Newswire - Tue Apr 02, 8:28AM CDT
Oncologix Tech Inc. (OTCBB: OCLG), a diversified medical device and healthcare company acquiring businesses in medical device cancer detection and prevention and healthcare services, has purchased all of the outstanding common stock of Dotolo Research Corporation. Dotolo is the leading global colon cleansing and bowel preparation medical device manufacturer, with more than two decades of product research, development and sales. Additional information can be found in the Company's Form 8-K as filed with the SEC.
